All Articles
1 min read
Стартапы2026年9月23日

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Marina Temkin·TechCrunch — AI
Original Source
Key Takeaways
  • 01.The round valued the AI biotech at $2 billion
  • 02.It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

This material is provided as an extended analytical summary.

Read full article at source
Aggregated within AI Qazaqstan national intelligence stream with author attribution.

Related Intelligence

All stories →
База знаний1 мин

新的全栈设计师

今天,Marvin Schwaibold 加入了我的行列,他是 Shopify 产品设计工作室的负责人。他将向我们展示他的幕后制作过程,>> [音乐] >> 我们将看到他如何使用最新的人工智能工具将他的设计变为现实,然后回顾一些观众提交的……

YouTube — Y Combinator AI